ZyGEM Releases Application Note Showing its DNA Extraction Kits Rapidly Produce High Yields of Quality DNA
--Highlights prepGEM(TM) Tissue Kit's Rapid, Robust and Reliable DNA Extraction That Generates DNA Templates Outperforming Other Commercial Kits--
-- Samples Prepared from Mouse Tails Using prepGEM(TM) Yielded Over 34 Times the Amount of DNA Produced by Two Commercial Rapid Extraction Kits --...
Mach One Completes Note Exchange
BELGIUM, Wis., Jan. 22 /PRNewswire-FirstCall/ -- Mach One Corporation
(Pink Sheets: MNCN), a biological solutions company that develops products
that produce a positive long term benefit to the agricultural and consumer
market, announced today that it has completed its Subordinated
Note Swap o...
Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
EVALUATION OF VARIOUS FINANCIAL AND RESTRUCTURING ALTERNATIVES ONGOING
VANCOUVER, Nov. 21 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that the Company had been notified ...
WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders' Meeting
OAKLAND, Calif., May 9 /PRNewswire-FirstCall/ -- (Nasdaq: WHRT, TSX:
WHT) Since January 2008, World Heart Corporation (the "Company") has
aggressively pursued various financing alternatives to raise additional
capital, including through equity financing transactions and corporate
collaboration...
ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase
TUCSON, Ariz., April 23 /PRNewswire-FirstCall/ -- ImaRx Therapeutics,
Inc. (Nasdaq: IMRX ) today announced that it has entered into an agreement
with Abbott Laboratories pursuant to which it has satisfied its obligations
under its $15 million non-recourse promissory
note with Abbott issued in...
Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38)
Evelyn McGown, Ph.D. , Michael Su, M.S. and Jin Liao, M.D., Ph.D.
Molecular Devices Corporation, 8/00
INTRODUCTION
Luciferase from the North American firefly (Photinus pyralis) is very popular foruse in Reporter Gene Assays. The enzyme catalyzes the AT...
Dual-Luciferase Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #39)
Evelyn McGown, Ph.D. and Michael Su, M.S.
Molecular Devices Corporation, 8/00
INTRODUCTION
Reporter gene assays are used to study eukaryotic gene expression. Dual geneticreporters are commonly used in transient transfections of cultured cells tominimiz...
High Sensitivity, Wide Dynamic Range, Horseradish Peroxidase (HRP) ELISA Using the LMax Microplate Luminometer (MaxLine Application Note #41)
Evelyn McGown, Ph.D. and Michael Su, M.S.
Molecular Devices Corporation, 8/00
INTRODUCTION
Immunoassays have traditionally employed colorimetric indicators. As such, multiple dilutions of samples were necessary to ensure that they fell within the dynam...
DNA Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #37)
Evelyn McGown, Ph.D. and Michael Su, M.S.
Molecular Devices Corporation, 8/00
INTRODUCTION
DNA measurements are important for many aspects of molecular biology. Of thespectrophotometric methods available, UV absorbance measurement at 260 nm isthe simpl...
ATP Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #40)
Evelyn McGown, Ph.D. and Michael Su, M.S.
Molecular Devices Corporation, 8/00
INTRODUCTION
Adenosine triphosphate (ATP) is present in all living cells. Because the level isstrictly-controlled, assay of ATP can be used as a indicator of viable cell numb...
Ca++-Induced G Protein Coupled Receptor (GPCR) Activation Monitored via Aequorin Luminescence in the LMax Microplate Luminometer (MaxLine Application Note #42)
Jinfang Liao, M.D., Ph.D. and Evelyn McGown, Ph.D.
Molecular Devices Corporation, 8/00
INTRODUCTION
The photoprotein aequorin, a bioluminescent protein from the coelentratejellyfish Aequorea victorea, has proven to be highly sensitive to the trace amou...
Verifying Multichannel Pipettor Performance with Standard Dispense Solutions in the SpectraMax Plus (MaxLine Application Note #28)
INTRODUCTION
Pipettors often fail to meet the manufacturers stated specifications 1- 5 and pipetting is a major source of laboratory error even when the pipettor is operating properly. Accuracy and precision specifications typically provided by pipettor manufacturer...
Using the SpectraMax Plus for USP Dissolution Calibration (MaxLine Application Note #27)
INTRODUCTION
Calibration of a dissolution apparatus is necessary to produce accurate results for dissolution testing of pharmaceutical dosage forms and to allow comparison between batches and between laboratories. USP requirements for calibration are given in the Appa...
UV Absorbance Measurements in SpectraMax Microplate Spectrophotometers MaxLine Application Note #32)
Evelyn McGown, Ph.D.
Molecular Devices Corporation. 7/99
In 1994, Molecular Devices introduced SPECTRAmax , the first microplate reader equipped with a monochromator, rather than bandpass filters, for wavelength selection. It was also the first microplate reader capable of m...
Microdetermination of Phosphorus Using the SpectraMax Plus Microplate Spectrophotometer: Choice of Microplate, Cuvette, or Test Tube Assay Formats (MaxLine Application Note #24)
INTRODUCTION
Most spectrophotometric methods for inorganic phosphorus (Pi) analysis are based on the color formed upon the reduction of a phosphomolybdate complex. The classic (and still widely-used) method is that of Fiske and Subbarow 1 , in which the reduction is c...
PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26)
INTRODUCTION
Protein concentration is commonly estimated by measuring the absorbance at 280 nm and calculating the concentration using the extinction coefficient of the protein. The procedure is feasible because extinction coefficients are typically obtained using sta...
Using the OligoGreen Oligonucleotide Quantitation Reagent in the Gemini XS, Gemini EM and SpectraMax M2 Microplate Readers (MaxLine Application Note #21)
By Yan Zhang., Molecular Devices Corporation, 1311 Orleans Dr., Sunnyvale, CA 94089.
Introduction
This application
note describes how to use the OliGreen Quantitation Kit from Molecular Probes in the Gemini XS, Gemini EM and SpectraMax M2 mic...
A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20)
INTRODUCTION
β -lactamases are either plasmid or chromosomally encoded bacterial enzymes which hydrolyze β -lactam antibiotics. The majority of β -lactamases produced by clinical isolates are serine active site enzymes. One successful approach to combat...
Using the NanoOrange protein kit in the Gemini XS, Gemini EM and SpectraMax M2 microplate readers (MaxLine Application Note #22)
By Yan Zhang, Molecular Devices Corporation, 1311 Orleans Dr., Sunnyvale, CA 94089.
INTRODUCTION
This application
note describes how to use the NanoOrange Protein Quantitation Kit from Molecular Probes in the Gemini XS, Gemini EM and SpectraMax M2 ...
Measurement of Molecular Beacons in the SpectraMax Gemini Spectrofluorometer (MaxLine Application Note #36)
Evelyn McGown and Michael Su
October 1999
Molecular beacons are fluorogenic oligonucleotide probes developed by Kramerand associates to detect specific nucleic acids in homogeneous solutions. 1 4 They are single-stranded oligonucleotides that exist in a hairpin shape becau...
Measurement of Green Fluorescent Protein in the SpectraMax Gemini XS Spectrofluorometer (MaxLine Application Note #44)
Simon Lydford 1 and Thomas Giller 2
1 Molecular Devices Limited and 2 Axovan Ltd.
INTRODUCTION
GFP (Green Fluorescent Protein) is an extremely stable protein of 238 amino acids produced by the jellyfish Aequorea victoria 1 that fluoresces in the lower green r...
LIVE/DEAD Viability/Cytotoxicity Assay for Animal Cells Using the SpectraMax Gemini XS Fluorescence Microplate Reader (MaxLine Application Note #43)
Anne T. Ferguson, Ph.D.
Molecular Devices Corporation
INTRODUCTION
This application
note describes the use of the SPECTRAmax GEMINI XS from Molecular Devices to study the performance of the LIVE/DEAD Viability/Cytoxicity Assay Kit for animal cells....
Fluorometric Protease Assays in the SpectraMax Gemini Microplate Spectrofluorometer: Example Using Caspase3 (MaxLine Application Note #35)
Evelyn McGown, Ph.D. and Anna Lam, B.S.
Molecular Devices Corporation, 8/99
INTRODUCTION
Modern assays for proteolytic activity typically use synthetic chromogenic or flu-orogenic peptide substrates. Enzyme selectivity is obtained by choosing a peptide...
Digital Healthcare Conference starts on a realistic note
Madison, Wis. Information technology managers in healthcare received a heavy dose of reality about IT integration in their field during the opening session of WTN Media's Digital Healthcare Conference .
The conference, which is being held May 3 and 4 at the Fluno Center on the University of ...
KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid
...mac e uti c al.com .
Cautionary
note Regarding Forward-looking Statements
The infor...imitation the litigation and claims referred to in
note 16 of the Notes to the Consolidated Financial Stat...y by the cautionary statements in this "Cautionary
note Regarding Forward-looking Statements" and the risk...
Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
...e closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.
Cautionary
note for Forward-Looking Statements. This press release contains forward-looking statements that reflect the Company's current expectations about its pros...
Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
...tal Inc., J.P. Morgan Securities Inc., and Lazard Capital Markets LLC are acting as co-managers. The common stock offering and the convertible senior
note offering are being conducted as separate public offerings by means of separate prospectus supplements, and neither of these offerings is contingent up...
SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
...x(TM), and MassARRAY((R)) are trademarks of SEQUENOM, Inc. All other trademarks and service marks are the property of their respective owners.
note to Investors
As previously announced, SEQUENOM will hold a conference call to discuss the second quarter and six-month financial results today, Aug...
PDI Reports 2009 Second Quarter Financial Results
...alth of strong leadership to the Board and I look forward to working more closely with him in the months and years to come.
"Finally, I want to
note that while we have begun to benefit from the pharmaceutical industry's strategic shift in outsourced sales, the first half of 2009 was particularly ch...
Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
... equity $59,823 $84,232
======= =======
note 1: Derived from audited financial statements included in the
Company's Annual Report on Form 10-K for the year ended
Decemb...
Beckman Coulter Completes Acquisition of Olympus' Lab-Based Diagnostics Business
...$780 million, which was funded as follows:
Approximately $495 million in net proceeds raised from the issuance of two $250 million senior
note offerings of 6- and 10- year maturities with 6% and 7% coupons, respectively.
Approximately $240 million in a common stock offering comprised of...
Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
...r current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should
note that many factors could affect our future financial results and could cause our actual results to differ materially from those expressed in forward-lo...
Sunesis Reports Financial Results for the Second Quarter 2009
...nd
stockholders' equity $9,785,803 $12,783,829
========== ===========
note 1: The condensed consolidated balance sheet as of December 31, 2008
has been derived from the audited financial statements as of that date
in...
Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.
...m domestic and international operations, including the matters described in
note 4-Uncertainty in Income Taxes-to the Consolidated Financial Statements in t...ich the Company operates, and (13) the outcome of the matters described in
note 13-Contingent Liabilities and Commitments-to the Consolidated Financial Sta...
American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification
... functionality and attributes of EHRs and how they are implemented will be critical to the successful implementation and use of these systems." As we
note in our formal comments, "Certifying an EHR does not necessarily equate with effectively using the system's available functions nor does implementation...
China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
...TIVITIES $(17,479,673) $(10,302,291)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issue of convertible
note $-- $25,000,000
Repayment on loan from shareholders -- --
NET CASH PROVIDED BY/(USED IN)
...
New drugs faster from natural compounds: A UC San Diego breakthrough
... a bioinformatics PhD student advised by Pavel Pevzner in computer science and Pieter Dorrestein in the Skaggs School of Pharmacy.
The researchers
note that currently there is no one place to look for known NRPs, a situation they are trying to change with a new data repository effort.
The UC San D...
Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances
...uire one common share for $0.044 expiring June 2014.
In July 2009, Viral Genetics issued 7,518,796 shares of common stock for conversion of a
note of $100,000 issued in July 2008 for the purchase of 49% of the common shares of an early-stage private business engaged in the marketing and design of...
Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax
...clinical signs of disease caused by exposure to a dose of aerosolized anthrax spores that was approximately 200 times the median lethal dose. We also
note that the safety profile shown in healthy human volunteers provides support for use of raxibacumab in the clinical setting of immediately life-threaten...
Verenium Completes Amendment to 8% Senior Convertible Notes
...e April 1, 2012 (the "Notes") entered into and announced on July 1, 2009 is effective as of 8:00 a.m. today. The Company has entered into Convertible
note Amendment Agreements with holders of 87% of the Notes, which is above the required 66.67% necessary to amend the outstanding Notes. Lazard Freres &am...